Evidence map›Paper›PMID 37513968›Full record

ArticlePharmaceutics2023

Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System.

Keli Jaqueline Staudt, Bruna Bernar Dias, Izabel Almeida Alves, Bénédicte Lelièvre, Jean-Philippe Bouchara, Bibiana Verlindo de Araújo

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Keli Jaqueline StaudtPharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre 90610-000, Brazil.
Bruna Bernar DiasPharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre 90610-000, Brazil.ORCID 0000-0002-4515-5263
Izabel Almeida AlvesFaculty of Pharmacy, Federal University of Bahia-UFBA, Salvador 40170-115, Brazil.
Bénédicte LelièvreUniversity of Angers-University of Brest, IRF (Infections Respiratoires Fongiques), SFR ICAT 4208, CEDEX 9, 49933 Angers, France.
Jean-Philippe BoucharaUniversity of Angers-University of Brest, IRF (Infections Respiratoires Fongiques), SFR ICAT 4208, CEDEX 9, 49933 Angers, France.
Bibiana Verlindo de AraújoPharmaceutical Sciences Graduate Program, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre 90610-000, Brazil.ORCID 0000-0002-9706-0389
Universidade Federal do Rio Grande do Sul · BRUniversité de Bretagne Occidentale · FRUniversidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voriconazole is a triazole antifungal used empirically for the treatment of complicated meningitis associated with

Indexed as

brain microdialysiscerebrospinal fluidcryptococcosisinterstitial space fluidmeningitisvoriconazole

Identifiers

PMID37513968
PMCPMC10384042
OpenAlexW4381662639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.